Legal Representation
Attorney
Frances M. Jagla
USPTO Deadlines
Next Deadline
47 days remaining
Statement of Use Due - Extension 3 Granted
Due Date
August 28, 2025
Extension Available
Until August 29, 2024
Application History
20 events| Date | Code | Type | Description |
|---|---|---|---|
| Feb 26, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Feb 26, 2025 | EX3G | S | SOU EXTENSION 3 GRANTED |
| Feb 25, 2025 | EXT3 | S | SOU EXTENSION 3 FILED |
| Feb 25, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Aug 1, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Aug 1, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Aug 1, 2024 | EXT2 | S | SOU EXTENSION 2 FILED |
| Aug 1, 2024 | EX2G | S | SOU EXTENSION 2 GRANTED |
| Feb 13, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Feb 12, 2024 | EX1G | S | SOU EXTENSION 1 GRANTED |
| Feb 12, 2024 | EXT1 | S | SOU EXTENSION 1 FILED |
| Feb 12, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Aug 29, 2023 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Jul 4, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Jul 4, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Jun 14, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Jun 1, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| May 31, 2023 | DOCK | D | ASSIGNED TO EXAMINER |
| Dec 1, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Nov 14, 2022 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
Pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of immunological disorders; pharmaceutical preparations for the treatment of graft versus host disorder (GVHD); pharmaceutical preparations for the treatment of hematological disorders; pharmaceutical preparations for the treatment of hypophosphatemia disorders; pharmaceutical preparations for the treatment of myeloproliferative disorders; pharmaceutical preparations for the treatment of skeletal or chondrocyte disorders; pharmaceutical preparations for the treatment of dermatological disorders; pharmaceutical preparations for the treatment of fibrotic disorders
Class 016
Printed brochures, newsletters, and pamphlets in the fields of medical issues, procedures, disease symptoms, patient support and community building
Class 044
Providing a medical information to healthcare providers and patients relating to viral, hematological, auto-immune, graft versus host, inflammatory, metabolic, fibrotic and dermatological disorders
Classification
International Classes
005
016
044